{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:47:28Z","timestamp":1769118448019,"version":"3.49.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T00:00:00Z","timestamp":1563062400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The subcutaneous implantable cardioverter-defibrillator (S-ICDTM) is an important advance in device therapy for the prevention of sudden cardiac death (SCD). Although current guidelines recommend S-ICDTM use, long-term data are still limited, especially in subgroups such as adult patients with congenital heart diseases. This cohort is of high interest because of the difficult anatomic conditions in these patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>All S-ICDTM patients with an underlying congenital heart disease (CHD) resulting in an indication for ICD implantation (n\u2009=\u200920 patients) in our large-scaled single-centre S-ICDTM registry (n\u2009=\u2009249 patients) were included in this study. Baseline characteristics, appropriate and inappropriate shocks, and complications were documented in a mean follow-up of 36\u2009months. Primary prevention of SCD was the indication for implantation of an S-ICDTM in six patients (30%). Of all 20 patients with an overall mean age of 40.5\u2009\u00b1\u200911.5\u2009years, 12 were male (60%). The mean left ventricular ejection fraction was 46.5\u2009\u00b1\u200911.3%. Nine episodes of ventricular tachycardia (two monomorphic and seven polymorphic) were adequately terminated in three patients (15%). In two patients, T-Wave-Oversensing resulting in an inappropriate shock was observed, which could be managed by changing the sensing vector or activation of the SMART PASSTM filter. There were no S-ICDTM system-related infections. In one patient, surgical revision was necessary due to a persistent haematoma.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The S-ICDTM seems to be a valuable option for the prevention of SCD in patients with various CHDs and complex anatomical anomalies. The S-ICDTM is safe and works effectively, also in these complex patients. Inadequate shock delivery was rare and could be managed by reprogramming.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/europace\/euz190","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T15:12:29Z","timestamp":1560957149000},"page":"1537-1542","source":"Crossref","is-referenced-by-count":12,"title":["The entirely subcutaneous ICDTM system in patients with congenital heart disease: experience from a large single-centre analysis"],"prefix":"10.1093","volume":"21","author":[{"given":"Kevin","family":"Willy","sequence":"first","affiliation":[{"name":"Department for Cardiology II: Electrophysiology, University Hospital M\u00fcnster, Albert-Schweitzer-Campus 1 Geb\u00e4ude A1, D M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Reinke","sequence":"additional","affiliation":[{"name":"Department for Cardiology II: Electrophysiology, University Hospital M\u00fcnster, Albert-Schweitzer-Campus 1 Geb\u00e4ude A1, D M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"B\u00f6geholz","sequence":"additional","affiliation":[{"name":"Department for Cardiology II: Electrophysiology, University Hospital M\u00fcnster, Albert-Schweitzer-Campus 1 Geb\u00e4ude A1, D M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"K\u00f6be","sequence":"additional","affiliation":[{"name":"Department for Cardiology II: Electrophysiology, University Hospital M\u00fcnster, Albert-Schweitzer-Campus 1 Geb\u00e4ude A1, D M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[{"name":"Department for Cardiology II: Electrophysiology, University Hospital M\u00fcnster, Albert-Schweitzer-Campus 1 Geb\u00e4ude A1, D M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1431-9886","authenticated-orcid":false,"given":"Gerrit","family":"Frommeyer","sequence":"additional","affiliation":[{"name":"Department for Cardiology II: Electrophysiology, University Hospital M\u00fcnster, Albert-Schweitzer-Campus 1 Geb\u00e4ude A1, D M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,7,13]]},"reference":[{"key":"2019101107585834400_euz190-B1","first-page":"1601","article-title":"ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"key":"2019101107585834400_euz190-B2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/pace.12885","article-title":"Inappropriate shocks in a patient with subcutaneous ICD and transvenous pacemaker: is it as it seems?","volume":"39","author":"Santucci","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"2019101107585834400_euz190-B3","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/CIRCULATIONAHA.112.104786","article-title":"Sudden cardiac death in adult congenital heart disease","volume":"126","author":"Koyak","year":"2012","journal-title":"Circulation"},{"key":"2019101107585834400_euz190-B4","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ahj.2009.08.014","article-title":"Mortality associated with adult congenital heart disease: trends in the US population from 1979 to 2005","volume":"158","author":"Pillutla","year":"2009","journal-title":"Am Heart J"},{"key":"2019101107585834400_euz190-B5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.107.738559","article-title":"Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery","volume":"117","author":"Khairy","year":"2008","journal-title":"Circulation"},{"key":"2019101107585834400_euz190-B6","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.hrthm.2015.02.035","article-title":"The clinical course of patients with implantable cardioverter-defibrillators: extended experience on clinical outcome, device replacements, and device-related complications","volume":"12","author":"van der Heijden","year":"2015","journal-title":"Heart Rhythm"},{"key":"2019101107585834400_euz190-B7","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/CIRCULATIONAHA.106.622076","article-title":"Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study","volume":"113","author":"Khairy","year":"2006","journal-title":"Circulation"},{"key":"2019101107585834400_euz190-B8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijcard.2015.09.083","article-title":"Subcutaneous implantable cardioverter defibrillators in children, young adults and patients with congenital heart disease","volume":"203","author":"Bordachar","year":"2016","journal-title":"Int J Cardiol"},{"key":"2019101107585834400_euz190-B9","doi-asserted-by":"crossref","first-page":"e004338","DOI":"10.1161\/CIRCEP.116.004338","article-title":"Clinical experience with the subcutaneous implantable cardioverter-defibrillator in adults with congenital heart disease","volume":"9","author":"Moore","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2019101107585834400_euz190-B10","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jacep.2016.02.008","article-title":"Outcomes in patients with congenital heart disease receiving the subcutaneous implantable-cardioverter defibrillator: results from a pooled analysis from the IDE study and the EFFORTLESS S-ICD registry","volume":"2","author":"D'Souza","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"2019101107585834400_euz190-B11","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jacc.2017.06.040","article-title":"Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study","volume":"70","author":"Boersma","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2019101107585834400_euz190-B12","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"2019101107585834400_euz190-B13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/chd.12433","article-title":"Readmissions after adult congenital heart surgery: frequency and risk factors","volume":"12","author":"Kim","year":"2017","journal-title":"Congenit Heart Dis"},{"key":"2019101107585834400_euz190-B14","doi-asserted-by":"crossref","first-page":"f240","DOI":"10.1093\/europace\/euy083","article-title":"Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies","volume":"20","author":"Brouwer","year":"2018","journal-title":"Europace"},{"key":"2019101107585834400_euz190-B15","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.amjcard.2017.08.051","article-title":"Incidence, predictors, and mortality of infective endocarditis in adults with congenital heart disease without prosthetic valves","volume":"120","author":"Mylotte","year":"2017","journal-title":"Am J Cardiol"},{"key":"2019101107585834400_euz190-B16","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/europace\/eux380","article-title":"Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE","volume":"20","author":"Hernandez-Madrid","year":"2018","journal-title":"Europace"},{"key":"2019101107585834400_euz190-B17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ccep.2016.10.008","article-title":"Ablation of ventricular tachycardia in congenital and infiltrative heart disease","volume":"9","author":"Wijnmaalen","year":"2017","journal-title":"Card Electrophysiol Clin"},{"key":"2019101107585834400_euz190-B18","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/eurheartj\/ehu112","article-title":"Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry","volume":"35","author":"Lambiase","year":"2014","journal-title":"Eur Heart J"},{"key":"2019101107585834400_euz190-B19","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/europace\/euv299","article-title":"The learning curve associated with the introduction of the subcutaneous implantable defibrillator","volume":"18","author":"Knops","year":"2016","journal-title":"Europace"},{"key":"2019101107585834400_euz190-B20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/pace.13017","article-title":"The role of conventional and right-sided ECG screening for subcutaneous ICD in a tetralogy of Fallot population","volume":"40","author":"Alonso","year":"2017","journal-title":"Pacing Clin Electrophysiol"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/21\/10\/1537\/30132585\/euz190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/21\/10\/1537\/30132585\/euz190.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T07:59:33Z","timestamp":1570780773000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/21\/10\/1537\/5532115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,13]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,7,13]]},"published-print":{"date-parts":[[2019,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euz190","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10]]},"published":{"date-parts":[[2019,7,13]]}}}